In the BioHarmony Drug Report Database

"Preview" Icon

Mirtazapine

Remeron, Remeron Soltab (mirtazapine) is a small molecule pharmaceutical. Mirtazapine was first approved as Remeron on 1996-06-14. It is used to treat depressive disorder in the USA. The pharmaceutical is active against alpha-2B adrenergic receptor, 5-hydroxytryptamine receptor 2C, alpha-2C adrenergic receptor, 5-hydroxytryptamine receptor 2A, and alpha-2A adrenergic receptor.

 

Trade Name

 

Remeron, Remeron Soltab
 

Common Name

 

mirtazapine
 

ChEMBL ID

 

CHEMBL654
 

Indication

 

depressive disorder
 

Drug Class

 

Tricyclic compounds

Image (chem structure or protein)

Mirtazapine structure rendering